Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role? | Haematologica
Diffuse Large B cell lymphoma (DLBCL) - Lymphoma Australia
Diffuse Large B-Cell Lymphoma: Changing Treatment Paradigms
Ibrutinib improves diffuse large B-cell lymphoma survival - NCI
New agents and regimens for diffuse large B cell lymphoma | Journal of Hematology & Oncology | Full Text
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients | Haematologica
The overall survival of in diffuse large B-cell lymphoma (DLBCL)... | Download Scientific Diagram
Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone
Survival analysis in patients with diffuse large B-cell lymphoma... | Download Scientific Diagram
Diffuse Large B-Cell Lymphoma | NEJM
Evolution of therapy for limited stage diffuse large B-cell lymphoma | Blood Cancer Journal
The Korean Journal of Internal Medicine
B-cell Function Gene Mutations in Diffuse Large B-cell Lymphoma: A Retrospective Cohort Study - eBioMedicine
Diffuse Large B-cell Lymphoma: Symptoms, Treatment and Prognosis: 9781634844024: Medicine & Health Science Books @ Amazon.com
Cancers | Free Full-Text | Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab
Emerging immunotherapy and strategies directly targeting B cells for the treatment of diffuse large B-cell lymphoma | Immunotherapy
Treatment resistance in diffuse large B-cell lymphoma | Leukemia
Determining Prognosis for Patients With Diffuse Large B-Cell Lymphoma - Hematology Advisor
Diffuse large B cell lymphoma: Outlook, stages, treatment
Biology Informs Treatment Choices in Diffuse Large B Cell Lymphoma: Trends in Cancer
Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial - The Lancet Haematology
Frontiers | Cancer Immunotherapy in Diffuse Large B-Cell Lymphoma
Prediction of Prognosis for Patients with Diffuse Large B-Cell Lymphoma Refractory to or in First Relapse After Initial R-CHOP Therapy: A Single-Institution Study | Anticancer Research
Prognosis for p65 hyperactivation in diffuse large B-cell lymphoma... | Download Scientific Diagram
